BioSpace News Archive

NeoGenomics, Inc. (NASDAQ:NEO), a leading oncology testing services company, announced today that the Molecular Diagnostics Services Program (MolDx) has conveyed coverage for the RaDaR assay, a personalized liquid biopsy for minimal residual disease (MRD) and recurrence detection.

Bristol Myers Squibb (NYSE:BMY) today reports results for the second quarter of 2023, which reflect continued execution against our strategic priorities.

Intellia Therapeutics, Inc. will present its second quarter 2023 financial results and operational highlights in a conference call on August 3, 2023, at 8 a.m. ET.

SIGA Technologies, Inc. today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesday, August 8th, 2023.

Kura Oncology, Inc. today announced that it will report second quarter 2023 financial results after the close of U.S. financial markets on Thursday, August 3, 2023.

Titan Pharmaceuticals, Inc. announced that it has entered into an Asset Purchase Agreement with Fedson, Inc., a Delaware Corporation, for the sale of certain ProNeura assets including Titan’s portfolio of drug addiction products, in addition to other early development programs based on the ProNeura drug delivery technology.

Precision BioSciences Provides Updates on Azer-Cel FDA Meeting, Potential Partnerships and Timing of In Vivo R&D Day.

Akari Therapeutics, Plc today announced that the European Commission granted orphan drug designation to nomacopan as a treatment in hematopoietic stem cell transplantation following the European Medicines Agency positive opinion in June.

Avalyn Pharma Inc. announced that CEO Lyn Baranowski will participate in the 43rd annual Canaccord Genuity Growth Conference, which is being held August 7-10, 2023 in Boston, MA.

Quoin Pharmaceuticals Ltd. announced today that the Company plans to release its second quarter 2023 financial results after the market closes on Wednesday, August 2, 2023.